Skip to content

The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

The Characteristics, Treatment Patterns and Prognosis of Chinese Male Breast Cancer: A Real-world Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06220630
Enrollment
1200
Registered
2024-01-24
Start date
2021-08-01
Completion date
2025-12-31
Last updated
2024-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Brief summary

The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is: * The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers. Researchers will investigate the features, survival associated factors and other relevant factors of this population.

Detailed description

The goal of this observational study is to investigate the features in Chinese male breast cancer (MBC) patients. The main question it aims to answer is: * The characteristics, treatment patterns and prognosis of Chinese MBC patients. The clinicopathological characteristics, treatment information and follow-up data of participants will be extracted from a Chinese national database (Chinese Society of Clinical Oncology Breast Cancer database) and other involved Chinese centers. Researchers will investigate the features, survival associated factors and other relevant factors of this population. The collected variables included: survival time, survival status, year of diagnosis, age, stage, molecular subtype statuses, histology, grade, and surgery, radiotherapy and systemic therapies utilization.

Interventions

OTHERBreast cancer

Male patients who were microscopically diagnosed as primary breast cancer.

Sponsors

Beijing Medical Award Foundation
CollaboratorUNKNOWN
The Affiliated Cancer Hospital of Xinjiang Medical University
CollaboratorUNKNOWN
Hebei Medical University Fourth Hospital
CollaboratorOTHER
The Third Affiliated Hospital of Kunming Medical University
CollaboratorUNKNOWN
Sun Yat-sen University
CollaboratorOTHER
The Affiliated Cancer Hospital of Zhengzhou University
CollaboratorUNKNOWN
The Third Hospital of Nanchang City
CollaboratorUNKNOWN
Beijing 302 Hospital
CollaboratorOTHER
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
CollaboratorOTHER
Fujian Provincial Hospital
CollaboratorOTHER
First Hospital of China Medical University
CollaboratorOTHER
The Affiliated Hospital of Qingdao University
CollaboratorOTHER
Guangdong Provincial People's Hospital
CollaboratorOTHER
First Affiliated Hospital Xi'an Jiaotong University
CollaboratorOTHER
First People's Hospital of Foshan
CollaboratorOTHER
Peking University First Hospital
CollaboratorOTHER
The Affiliated Hospital Of Guizhou Medical University
CollaboratorOTHER
Guangdong Provincial Hospital of Traditional Chinese Medicine
CollaboratorOTHER
Jiangmen Central Hospital
CollaboratorOTHER
The Second Affiliated Hospital, Guangzhou Medical University
CollaboratorUNKNOWN
The First Affiliated Hospital, Zhejiang University
CollaboratorUNKNOWN
Peking University Shenzhen Hospital
CollaboratorOTHER
The Second Affiliated Hospital of Harbin Medical University
CollaboratorOTHER
Affiliated Sanming First Hospital of Fujian Medical University
CollaboratorUNKNOWN
Jieyang People's Hospital
CollaboratorOTHER
National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital
CollaboratorUNKNOWN
Shantou Central Hospital
CollaboratorOTHER
The First Affiliated Hospital with Nanjing Medical University
CollaboratorOTHER
Lianjiang Pepole's Hospital, Lianjiang
CollaboratorUNKNOWN
Guangdong Women and Children Hospital
CollaboratorOTHER
Zhanjiang Central Hospital
CollaboratorUNKNOWN
Zhuhai Hospital of Integrated Traditional Chinese and Western Medicine
CollaboratorUNKNOWN
First Affiliated Hospital, Sun Yat-Sen University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Biological sex is male; * Microscopically diagnosed as primary breast cancer.

Exclusion criteria

* Presence of skin-origin malignancy on the breast.

Design outcomes

Primary

MeasureTime frameDescription
Overall survivalFrom the time of diagnosis to August 1, 2024 (anticipated).The duration between the date of the first pathologic diagnosis and death from any cause or last follow-up.

Countries

China

Contacts

Primary ContactYuxuan Gao, MD
gaoyx9@mail2.sysu.edu.cn+86 18142846375

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026